Open-Label, Fixed-Sequence Study To Estimate The Pharmacokinetic Interaction Between Multiple Dose Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Trial Profile

Open-Label, Fixed-Sequence Study To Estimate The Pharmacokinetic Interaction Between Multiple Dose Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2014

At a glance

  • Drugs Maraviroc (Primary) ; Fosamprenavir; Ritonavir
  • Indications HIV infections; Hypertriglyceridaemia
  • Focus Pharmacokinetics
  • Sponsors ViiV Healthcare
  • Most Recent Events

    • 28 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jun 2011 Planned End Date changed from 1 May 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
    • 04 May 2011 Actual initiation date (April 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top